Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Oct-24 5:00 PM View:  | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 09-Oct-24 | Sale | 476 | $0.45 | $212.30 | (3%) 18.49K to 18.01K | |
| 03-Jul-24 2:34 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 02-Jul-24 | Sale | 621 | $1.07 | $664.47 | (3%) 19.11K to 18.49K | |
| 03-Jul-24 2:33 PM View: | Sapirstein James Chairman and CEO Director | Entero Therapeutics, Inc. (ENTO) | 02-Jul-24 | Sale | 1,289 | $1.07 | $1,379.23 | (3%) 37.1K to 35.82K | |
| 12-Jun-24 6:23 PM View: | Khosla Chaitan Phd Director | Entero Therapeutics, Inc. (ENTO) | 11-Jun-24 | Grant | 24,889 | -- | -- | 5657% 0.44K to 25.33K | |
| 03-Apr-24 5:13 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 01-Apr-24 | Private Sale | 75 | $4.23 | $317.20 | (< 1%) 19.19K to 19.11K | |
| 03-Apr-24 5:14 PM View: | Sapirstein James Chairman and CEO Director | Entero Therapeutics, Inc. (ENTO) | 01-Apr-24 | Private Sale | 174 | $4.23 | $735.92 | (< 1%) 37.28K to 37.1K | |
| 19-Mar-24 4:10 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 15-Mar-24 | Private Sale | 1,120 | $4.96 | $5,555.20 | (6%) 20.31K to 19.19K | |
| 19-Mar-24 4:13 PM View: | Sapirstein James Chairman and CEO Director | Entero Therapeutics, Inc. (ENTO) | 15-Mar-24 | Private Sale | 1,887 | $4.96 | $9,359.52 | (5%) 39.17K to 37.28K | |
| 15-Mar-24 6:05 PM View: | Khosla Chaitan Phd Director | Entero Therapeutics, Inc. (ENTO) | 13-Mar-24 | Grant | 440 | -- | -- | 100% 0 to 0.44K | |
| 15-Mar-24 6:05 PM View: | Syage Jack President & COO Director | Entero Therapeutics, Inc. (ENTO) | 13-Mar-24 | Grant | 15,400 | -- | -- | 100% 0 to 15.4K | |
| 17-Jan-24 4:02 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 12-Jan-24 | Private Sale | 98 | $4.20 | $411.60 | (< 1%) 20.4K to 20.31K | |
| 17-Jan-24 4:01 PM View: | Sapirstein James Chairman, President and CEO Director | Entero Therapeutics, Inc. (ENTO) | 12-Jan-24 | Private Sale | 166 | $4.20 | $697.20 | (< 1%) 39.33K to 39.17K | |
| 04-Jan-24 5:13 PM View: | Coelho Mary Theresa Director | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 19,633 | -- | -- | 3251% 0.6K to 20.24K | |
| 03-Jan-24 7:54 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 7,000 | -- | -- | 52% 13.4K to 20.4K | |
| 03-Jan-24 7:55 PM View: | Sapirstein James Chairman, President and CEO Director | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 20,000 | -- | -- | 103% 19.33K to 39.33K | |
| 04-Jan-24 5:12 PM View: | Borkowski Edward Director | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 19,633 | -- | -- | 3192% 0.61K to 20.25K | |
| 04-Jan-24 5:13 PM View: | Riddell Alastair Director | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 19,633 | -- | -- | 3234% 0.61K to 20.24K | |
| 04-Jan-24 5:14 PM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 19,633 | -- | -- | 6458% 0.3K to 19.94K | |
| 03-Jan-24 7:55 PM View: | Sapirstein James Chairman, President and CEO Director | Entero Therapeutics, Inc. (ENTO) | 29-Dec-23 | Grant | 17,660 | -- | -- | 1056% 1.67K to 19.33K | |
| 03-Jan-24 7:54 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 29-Dec-23 | Grant | 12,614 | -- | -- | 1597% 0.79K to 13.4K | |
| 06-Oct-23 4:05 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 04-Oct-23 | Sale | 1,676 | $0.29 | $486.04 | (10%) 17.48K to 15.8K | |
| 06-Oct-23 4:04 PM View: | Sapirstein James President and CEO Director | Entero Therapeutics, Inc. (ENTO) | 04-Oct-23 | Sale | 2,764 | $0.29 | $801.56 | (8%) 36.16K to 33.4K | |
| 18-Sep-23 5:44 PM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 15-Sep-23 | Sale | 10 | $0.43 | $4.30 | (< 1%) 6.11K to 6.1K | |
| 05-Sep-23 8:08 PM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 31-Aug-23 | Sale | 6,053 | $0.30 | $1,815.90 | (50%) 12.16K to 6.11K | |
| 05-Jul-23 4:28 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 03-Jul-23 | Sale | 1,977 | $1.54 | $3,044.58 | (10%) 19.45K to 17.48K | |
| 05-Jul-23 4:27 PM View: | Sapirstein James President and CEO Director | Entero Therapeutics, Inc. (ENTO) | 03-Jul-23 | Sale | 3,349 | $1.54 | $5,157.46 | (8%) 39.51K to 36.16K | |
| 05-Apr-23 4:07 PM View: | Sapirstein James President and CEO Director | Entero Therapeutics, Inc. (ENTO) | 03-Apr-23 | Sale | 3,347 | $2.50 | $8,367.50 | (8%) 42.86K to 39.51K | |
| 05-Apr-23 4:17 PM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 03-Apr-23 | Sale | 1,975 | $2.50 | $4,937.50 | (9%) 21.43K to 19.45K | |
| 05-Jan-23 8:58 AM View: | Borkowski Edward Director | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 84,745 | -- | -- | 6006% 1.41K to 86.16K | |
| 05-Jan-23 8:53 AM View: | Riddell Alastair Director | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 84,745 | -- | -- | 19260% 0.44K to 85.19K | |
| 05-Jan-23 8:56 AM View: | Hoffman David Andrew Director | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 84,745 | -- | -- | 1405% 6.03K to 90.78K | |
| 05-Jan-23 9:01 AM View: | Romano Sarah Chief Financial Officer | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 150,000 | -- | -- | 100% 0 to 150.0K | |
| 05-Jan-23 8:55 AM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 84,745 | -- | -- | 21785% 0.39K to 85.13K | |
| 05-Jan-23 9:00 AM View: | Sapirstein James President and CEO Director | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 300,000 | -- | -- | 100% 0 to 300.0K | |
| 05-Jan-23 9:02 AM View: | Coelho Mary Theresa Director | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 84,745 | -- | -- | 100% 0 to 84.75K | |
| 23-Mar-20 8:15 PM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 19-Mar-20 | Gift | 9,000 | -- | -- | (4%) 234.0K to 225.0K | |
| 23-Mar-20 8:15 PM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 19-Mar-20 | Gift | 9,000 | -- | -- | 4% 225.0K to 234.0K | |
| 13-Mar-20 4:10 PM View: | Schramm Vern Lee Director | Entero Therapeutics, Inc. (ENTO) | 11-Mar-20 | Grant | 22,998 | $0.76 | $17,501.00 | 34% 67.5K to 90.5K | (48%) |
| 13-Mar-20 4:10 PM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 11-Mar-20 | Grant | 22,998 | $0.76 | $17,501.00 | 24% 94.0K to 117.0K | (48%) |
| 13-Mar-20 4:10 PM View: | Riddell Alastair Director | Entero Therapeutics, Inc. (ENTO) | 11-Mar-20 | Grant | 29,294 | $1.45 | $42,405.70 | 29% 102.75K to 132.05K | |
| 13-Mar-20 4:10 PM View: | Borkowski Edward Director | Entero Therapeutics, Inc. (ENTO) | 10-Mar-20 | Grant | 30,647 | $1.75 | $53,757.20 | 8% 392.81K to 423.45K | (< 1%) |
| 03-Jan-20 4:11 PM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 31-Dec-19 | Grant | 7,500 | $1.04 | $7,800.00 | 9% 86.5K to 94.0K | (63%) |
| 03-Jan-20 10:00 PM View: | Riddell Alastair Director | Entero Therapeutics, Inc. (ENTO) | 31-Dec-19 | Grant | 7,500 | $1.04 | $7,800.00 | 8% 92.5K to 100.0K | (63%) |
| 03-Jan-20 9:45 PM View: | Borkowski Edward Director | Entero Therapeutics, Inc. (ENTO) | 31-Dec-19 | Grant | 7,500 | $1.04 | $7,800.00 | 2% 385.31K to 392.81K | (63%) |
| 03-Jan-20 4:06 PM View: | Schramm Vern Lee Director | Entero Therapeutics, Inc. (ENTO) | 31-Dec-19 | Grant | 7,500 | $1.04 | $7,800.00 | 12% 60.0K to 67.5K | (63%) |
| 10-Oct-19 9:11 PM View: | Sapirstein James PRESIDENT AND CEO Director | Entero Therapeutics, Inc. (ENTO) | 08-Oct-19 | Grant | 200,000 | -- | -- | 100% 0 to 200.0K | |
| 01-Oct-19 2:29 PM View: | Riddell Alastair Director | Entero Therapeutics, Inc. (ENTO) | 30-Sep-19 | Grant | 7,500 | $0.60 | $4,500.00 | 9% 85.0K to 92.5K | (38%) |
| 01-Oct-19 2:24 PM View: | Borkowski Edward Director | Entero Therapeutics, Inc. (ENTO) | 30-Sep-19 | Grant | 7,500 | $0.60 | $4,500.00 | 2% 377.81K to 385.31K | (38%) |
| 01-Oct-19 2:25 PM View: | Schramm Vern Lee Director | Entero Therapeutics, Inc. (ENTO) | 30-Sep-19 | Grant | 7,500 | $0.60 | $4,500.00 | 14% 52.5K to 60.0K | (38%) |
| 01-Oct-19 2:27 PM View: | Casamento Charles J Director | Entero Therapeutics, Inc. (ENTO) | 30-Sep-19 | Grant | 7,500 | $0.60 | $4,500.00 | 9% 79.0K to 86.5K | (38%) |
